Showing 1–25 of 81 documents
Sorted by hybrid relevance (keyword + semantic via RRF)
Woo Joo Kim, M.D, Ph.D
Healthy adults will be once administered GC3107(BCG Vaccine) Intradermally. Healthy adults will be once administered GC3107(BCG Vaccine) Intradermally. Tuberculin Skin Test(TST) will be conducted after 84+7 days after IP injection and TST result will be read in 48\~72 hours.
Helen McShane
This is a human pilot study of 16 healthy BCG-naïve volunteers to quantify BCG from the BCG vaccination site. Volunteers will be vaccinated with BCG. The first 8 will go on to have a punch biopsy and suction blister of the vaccination sites at 2 weeks post vaccination (arm A) the…
Mark F. Cotton, Helena Rabie
…lth Organization, Geneva2015Google Scholar and an effective vaccine was a key component of this strategy. Although tuberculosis vaccine research began in earnest in the 1990s, a strategic blueprint for tuberculosis vaccine development beyond the BCG vaccine was released in 2012. …
Wenping Gong, Jianping Xie, Hao Li, Ashok Aspatwar
…/tuberculosis). However, it is reported that the protective efficacy of BCG is highly variable and ranges between 0% and 80%, and its protection lasts only for 10 to 15 years [2]. Therefore, developing a new effective TB vaccine is pressing and challenging for governments and sci…
Ahmed M. Abbas, Asmaa Abou‐Bakr, Nermeen Bahaa, Sherry Michael, Marco Ghobrial, et al.
… relationship between COVID-19 and Bacille Calmette Guérin (BCG) vaccine is still under investigation, and we aim to clarify this matter. Bacille Calmette Guérin is a live attenuated tuberculosis vaccine. BCG vaccination of adult humans induces strained circulating monocytes havi…
Mark F. Cotton, Helena Rabie
… control through vaccination remains a global priority. The efficacy of BCG given to neonates to prevent tuberculosis meningitis and miliary tuberculosis is well known.1Trunz BB Fine P Dye C Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis wo…
Fadel Sayes, Wafa Frigui, Alexandre Pawlik, Cécile Tillier, Magali Tichit, et al.
Abstract The currently licensed anti-tuberculosis (TB) vaccine, Mycobacterium bovis BCG, provides limited protection against pulmonary TB in adolescents and adults, the main cause of TB transmission and mortality. To obtain an improved BCG-based vaccine candidate with increased i…
Eloise T. M. Filardi, Roberto Carlos Cruz Carbonell, Fernando R. Pavan, Felipe A. Cerni, Manuela B. Pucca
Vaccines represent one of the most significant achievements in medical science, constituting safe preparations or substances developed with the primary purpose of stimulating the immune system (1,2). Their central function is to protect the human body against a myriad of infectio…
Helen McShane
…nd highly immunogenic in mycobacterially naïve individuals, BCG vaccinated individuals and M.tb latently infected individuals. We will use the same vaccination regime in this study. Participants will be defined as being infected with M.tb.if they have a positive Elispot response …
Eskild Petersen, Martin Rao, Giuseppe Ippolito, Gina Gualano, Jeremiah Chakaya, et al.
…uch-needed resources to find, diagnose and treat 40 million adults and children who will be affected by TB by 2022, and to conduct research on new diagnostics, treatments and vaccines required to achieve global TB control (Tiberi et al., 2018Tiberi S. Petersen E. Maeurer M. Ntoum…
Helen McShane, Dr
…erially naïve individuals, those previously vaccinated with BCG and latently infected individuals. Additionally, 5 x 10\^7 pfu MVA containing HIV antigens administered twice, 4 weeks apart, in HIV positive individuals, is safe. We will use 5 x 107 pfu MVA85A intradermally in this…
Hafsa Farooq, Hamna Khan, Nimra Akhtar
…ost TB cases (95%) are found in low-income nations. Neonate BCG immunization is recommended by the WHO in countries with a "high prevalence" of tuberculosis.Objective: To determine the frequency of BCG vaccination in children diagnosed with pulmonary Tuberculosis at a tertiary ca…
Helen McShane
…ally naïve individuals and those previously vaccinated with BCG. We will use the same vaccination regime in this study. Subjects will be defined as being latently infected if they have a positive elispot response to ESAT6 or CFP10. Subjects will be identified from TB contact clin…
Padmini Salgame, Vaishnavi Kaipilyawar
…or the largely variable protective effect against TB of the vaccine Bacille Calmette-Guerin (BCG) is not understood.In this study, we investigated whether epigenetic mechanisms are involved in the response of immune cells to the BCG vaccine.We isolated peripheral blood mononuclea…
Serum Institute of India Pvt. Ltd.
This is a Phase II/III trial with two groups of adults successfully cured of category 1 pulmonary TB receiving either VPM1002 or placebo. Single dose of VPM1002 / placebo will be administered to calculate efficacy of the vaccine against TB recurrence. The study is designed as a …
Helen McShane
…d HIV present major new challenges. The currently available vaccine, M. bovis BCG, is largely ineffective at protecting against adult pulmonary disease in endemic areas and it is widely agreed that a new more effective tuberculosis vaccine is a major global public health priority…
Helen McShane
This study is preliminary to proving that this vaccine could protect against tuberculosis in humans. Although there is no proven data to show that infants will benefit directly from participation in this study by being protected against TB, MVA85A protection of mice, guinea pigs …
Özgül Kısa
…iency Syndrome (AIDS). Currently, Bacillus Calmette-Guérin (BCG) vaccine is used to prevent tuberculous meningitisand miliary disease, particularly in young children, but its protective efficacy is variable in adults. Therefore, there isan urgent need for the development of alter…
Ahyar Ahmad, Andriansjah Rukmana, Miski Aghnia Khairinisa, Dian Ayu Eka Pitaloka, Rosana Agus, et al.
…h challenge worldwide. Currently, Bacillus Calmette-Guerin (BCG) is the only vaccine available for TB prophylaxis. However, the efficacy of the BCG vaccine against adult pulmonary TB is considered inconsistent. This condition encourages researchers to look for more effective opti…
Mark Hatherill, MD, FCPaed
Rationale: The Bacille Calmette-Guérin (BCG) vaccine protects children against disseminated tuberculosis (TB) including TB meningitis and miliary TB, but efficacy against pulmonary TB is inconsistent among children and adults. Administration of live attenuated BCG to infants know…
Usama Sajjad, Khalid Khan Niazi, Gillian Beamer, Metin N. Gürcan
…over 2 billion individuals worldwide. Although the approved vaccine against TB, <i>M. bovis</i> Bacille Calmette-Guerin (BCG), successfully prevents TB meningitis and systemic TB in children, efficacy against pulmonary TB in adults is highly variable, ranging from 0% to 80…
Aishwarya Venkataraman, MRCPCH
Bacille Calmette Guerin (BCG) vaccine is one of the most used vaccines of the world, to reduce the risks of natural tuberculous infection. The efficacy of BCG vaccination in newborns is well known and has a documented protective effect against meningitis and disseminated TB in ch…
Thomas E. Tavolara, Muhammad Khan Niazi, Gillian Beamer, Metin N. Gürcan
…utcomes, vaccination with M. bovis Bacille Calmette-Guerin (BCG) vaccine is used globally in children to prevent systemic disease and tuberculous meningitis. However, in adults, epidemiological studies show variable protection ranging from 0% to 80%. As a part of a larger study t…
Helen McShane
…aring two different strains of the Bacille Calmette-Guérin (BCG) vaccine at standard and high dose. Currently, to assess vaccine efficacy against tuberculosis (TB) there is no alternative to large randomized controlled trials. These efficacy trials for novel TB vaccines are diff…
Stephen Gordon, MD
Despite tremendous efforts, an effective tuberculosis (TB) vaccine remains elusive. TB continues to infect and kill many. In 2021, TB infected more than 10 million and killed 1.6 million people. To date, the M.bovis bacille Calmette Guerin (BCG) is the only licensed vaccine again…